A retrospective cohort study analysing comparative risk of falls/fractures and all-cause hospitalizations among older adults with dementia and overactive bladder
Latest Information Update: 17 May 2021
At a glance
- Drugs Darifenacin (Primary) ; Fesoterodine (Primary) ; Oxybutynin (Primary) ; Solifenacin (Primary) ; Tolterodine (Primary) ; Trospium chloride (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- 17 May 2021 New trial record
- 01 May 2021 Results published in the International Journal of Geriatric Psychiatry